How oxytocin affects social rewards differently in males and females
Sex-dependent regulation of social reward by oxytocin in the mesolimbic reward circuitry
This study looks at how the hormone oxytocin affects the way male and female Syrian hamsters experience the joy of social interactions, which could help us understand more about social behavior and improve treatments for related disorders.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia State University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11036244 on NIH RePORTER |
What this research studies
This research investigates how oxytocin, a hormone linked to social bonding, influences the reward value of social interactions in both male and female Syrian hamsters. By examining the mesolimbic dopamine system, which is crucial for processing rewards, the study aims to uncover the neural mechanisms that differentiate social reward experiences between sexes. The research employs a series of integrated hypotheses and experimental approaches to explore these differences, potentially leading to insights that could inform treatments for social behavior disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals interested in the biological and hormonal influences on social behavior, particularly those affected by social interaction disorders.
Not a fit: Patients who do not have issues related to social behavior or hormonal imbalances may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of social behavior and lead to improved treatments for conditions related to social interaction, such as addiction or social anxiety.
How similar studies have performed: While the role of oxytocin in social behavior has been studied, this specific investigation into sex differences in social reward is relatively novel and has not been extensively tested.
Where this research is happening
Atlanta, United States
- Georgia State University — Atlanta, United States (Active)
Researchers
- Principal investigator: Albers, H. Elliott — Georgia State University
- Study coordinator: Albers, H. Elliott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.